Trial intelligence / Profile preview

Double-blind, placebo-controlled randomized phase 2 trial of lithium carbonate in multiple system atrophy

2009-016377-15Phase 2Active

Sponsor
University of Naples Federico II
Start
Oct 2009
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in multiple system atrophy (MSA) comparing Lithium carbonate with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Oct 2009; status: active.

02

Drugs

lithium carbonate
03

Conditions

multiple system atrophy (MSA)

Beyond the preview

Go deeper on 2009-016377-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016377-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call